MedPath

Lidocaine Patches Prior to Intravenous Insertion

Phase 2
Completed
Conditions
Need for Intravenous Catheter
Interventions
Device: Lidocaine tetracaine
Device: Placebo
Registration Number
NCT00552695
Lead Sponsor
Stony Brook University
Brief Summary

This study will determine whether application of a patch containing a topical anesthetic (numbing medicine) named lidocaine can reduce the pain of subsequent insertion of an intravenous catheter in Emergency Department patients.

Detailed Description

Patients will be randomly assigned to an active lidocaine patch or a patch that conatins a placebo or inactive agent. Neither the patient nor the practitioner will know which patch is used since they will appear identical.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Age greater than or equal to 3,
  • Need for non-emergent intravenous catheter
Exclusion Criteria
  • Unstable patients,
  • Allergy to lidocaine or tetracaine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Lidocaine tetracaineLidocaine 70 mg/tetracaine 70 mg skin patch
2Placebo-
Primary Outcome Measures
NameTimeMethod
Pain on Visual Analog Scale (VAS)0 MINUTES

Pain on 100 mm Visual Aanalog Scale from 0 (no pain) to 100 (most pain).

Secondary Outcome Measures
NameTimeMethod
Success of Intravenous (IV) InsertionAfter first attempt of catheter insertion

Percentage of patients in whom intravenous catheter was inserted successfully

Trial Locations

Locations (1)

Stony Brook University Hospital

🇺🇸

Stony Brook, New York, United States

© Copyright 2025. All Rights Reserved by MedPath